Posts by: Margarida Azevedo, MSc

Margarida Azevedo, MSc

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

February 23, 2017

Biosimilar Inflectra Matches Remicade as Crohn’s Treatment, Trial Results Show

News

The biosimilar therapy Inflectra (infliximab CT-P13) is as good a treatment as Remicade (infliximab) for those with moderate-to-severe Crohn’s disease (CD), according to the results of a clinical trial. Pfizer and Celltrion Healthcare, ... Read more

February 22, 2017February 22, 2017

A Crohn’s Setback Leaves Her Wondering About the Future

Columns, Crohn's Corner - a column by Judy Walters

So, I was all the way down to a 5 mg dose of prednisone last week and the inevitable happened; I started feeling sick. I had been feeling pretty good ... Read more

February 20, 2017May 23, 2017

Janssen Reports Positive 2-Year Results for Stelara as Crohn’s Treatment

News

Janssen-Cilag International reported results from its ongoing IM-UNITI long-term extension (LTE) clinical trial assessing the efficacy and safety of subcutaneous (SC) Stelara (ustekinumab) in patients with moderate to severe Crohn’s ... Read more

February 15, 2017February 15, 2017

Crohn’s and Colitis Canada Invites Young People with IBD to Apply for Camp Program and Academic Scholarships

News

Crohn’s and Colitis Canada is inviting children and teens in Canada with inflammatory bowel diseases (IBDs) to take part in two programs, Camp Got2Go and the AbbVie IBD Scholarships. The Camp Got2Go initiative ... Read more

February 15, 2017February 15, 2017

Crohn’s Hasn’t Made Me a Better Person

Columns, Crohn's Corner - a column by Judy Walters

Perhaps I sound bitter, but I understood how people with serious chronic illness say that they are so much better, happier, more fulfilled, stronger, or a new person since being diagnosed with ... Read more

February 14, 2017

RedHill Enrolls Last Patient in Bekinda Phase 3 Trial for Acute Gastroenteritis

News

RedHill Biopharma has enrolled the last patient in a Phase 3 clinical evaluating Bekinda (24 mg) for the treatment of acute gastroenteritis and gastritis. The drug, targeting multiple gastrointestinal indications, is also ... Read more

February 13, 2017

Whole Grains Shown to Improve Gut Microbiota and Immune Response in New Study

News

Consuming a diet rich in whole grains rather than refined grains has been shown to bring modest improvements to the gut microbiota and to reduce inflammation — and could potentially ... Read more

February 8, 2017

Low Vitamin D Levels Linked to Increased Risk of UC Relapse Among Patients in Remission

News

Low vitamin D serum levels during periods of clinical remission increase the risk of relapse in patients with ulcerative colitis (UC), a new study shows. The results indicate that patients ... Read more

February 8, 2017February 8, 2017

After ‘Taking One for the Team’ for Years, It’s Good to Know I’m a Member

Columns, Crohn's Corner - a column by Judy Walters

While growing up, I never felt as if I was a part of a team. I was the second of four children. The oldest was a boy and the two ... Read more

February 7, 2017

GB Sciences Seeks Patent for Cannabis-based Treatment for Bowel Diseases

News

GB Sciences is seeking a patent for marijuana-based mixtures capable of preventing and treating several inflammatory disorders, including inflammatory bowel disease (IBD). The patent application involves using cannabinoid-containing complex mixtures (CCCM) to disrupt the ... Read more